Intraoperative ERCP Versus Therapeutic Splitting in Cholecysto-, Choledocholithiasis
Benefits and Advantages of Intraoperative ERCP Versus Therapeutic Splitting in Cholecysto-, Choledocholithiasis in a High Expertise Center
1 other identifier
observational
200
1 country
1
Brief Summary
At the Kepler University Hospital Linz all variants of ERCP (preoperative, intraoperative, postoperative ERCP) are performed in cases of simultaneous cholecysto- and choledocholithiasis. Hardly any other hospital in Austria prefers intraoperative ERCP or offers it at all. A standardized procedure with implemented logistics has been established. This study compares intraoperative and postoperative ERCP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedFirst Submitted
Initial submission to the registry
November 8, 2023
CompletedFirst Posted
Study publicly available on registry
November 14, 2023
CompletedMarch 6, 2025
November 1, 2023
3.5 years
November 8, 2023
March 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Post-ERCP Pancreatitis
radiological/blood sample/pain
48 hours after intervention
Secondary Outcomes (6)
LOS
9 months after first admission
Surgical method
at surgery
Re-choledocholithiasis
up to one year after first admission
Re-Intervenition
30 days after surgery and/or ERCP
Successful ERCP
at ERCP
- +1 more secondary outcomes
Study Arms (2)
Intraoperative ERCP
Patients with cholecystocholedocholithiasis getting intraoperative ERCP
Splitting
Patients with cholecystocholedocholithiasis getting therapeutic splitting
Interventions
endoscopical clearance of the common bile duct
Eligibility Criteria
All patients undergoing surgery and ERCP in context to cholecysto-, choledocholithiasis in out hospital
You may qualify if:
- simultaneous cholecysto-, choledocholithiasis
- emergency or elective
- confirmed choledocholithiasis
- intraoperative ERCP
- preoperative ERCP followed by cholecystectomy
- postoperative ERCP
You may not qualify if:
- \- \< 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kepler University Hosital Linz
Linz, Austria, 4020, Austria
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Andreas Shamiyeh, Dr.
Kepler University Hospital Linz
- PRINCIPAL INVESTIGATOR
Sandra Raab, Dr.
Kepler University Hospital Linz
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. med. univ.
Study Record Dates
First Submitted
November 8, 2023
First Posted
November 14, 2023
Study Start
January 1, 2020
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
March 6, 2025
Record last verified: 2023-11